Isochroman-6-carboxamides as Highly Selective 5-HT_1D Agonists: Potential New Treatment for Migraine without Cardiovascular Side Effects

This publication has 10 references indexed in Scilit:

• Characterization of ligand binding properties of the 5-HT1D receptors cloned from chimpanzee, gorilla and rhesus monkey in comparison with those from the human and guinea pig receptors
  Neuroscience Letters, 1997
• Impact of Sumatriptan on Workplace Productivity, Nonwork Activities, and Health‐Related Quality of Life Among Hospital Employees With Migraine
  Headache: The Journal of Head and Face Pain, 1996
• (S)-(−)-4-[4-[2-(Isochroman-1-yl)ethyl]piperazin-1-yl]benzenesulfonamide, a Selective Dopamine D₄ Antagonist
  Journal of Medicinal Chemistry, 1996
• Selective 5-HT1D alpha serotonin receptor gene expression in trigeminal ganglia: implications for antimigraine drug development.
  Proceedings of the National Academy of Sciences, 1994
• Stimulation of central 5-HT1D receptors causes hypothermia in the guinea-pig
  Journal of Psychopharmacology, 1994
• 5-HT1 receptors mediating contraction in bovine cerebral arteries: a model for human cerebrovascular ‘5-HT1Dβ‘ receptors
  European Journal of Pharmacology, 1993
• Healthcare Resource and Lost Labour Costs of Migraine Headache in the US
  PharmacoEconomics, 1992
• Human serotonin 1D receptor is encoded by a subfamily of two distinct genes: 5-HT1D alpha and 5-HT1D beta.
  Proceedings of the National Academy of Sciences, 1992
• Di-tert-butyl N-acylimidodicarbonates as isolable acylating agents: mild conversion of primary carboxamides to substituted amides
  The Journal of Organic Chemistry, 1991
• The antimigraine drug, sumatriptan (GR43175), selectively blocks neurogenic plasma extravasation from blood vessels in dura mater
  British Journal of Pharmacology, 1990